VIENNA—Estrogen receptor negative breast cancer might be prevented by strategies under investigation including HER2-targeting, vaccination and treatment with metformin or retinoids. Powel Brown MD, Chairman of the Department of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center in Houston, summarized the evidence for Oncology Times reporter Sarah.
You may also like...
Audio Journal of Oncology in Advance – November 15th, 2006 15 Nov, 2006 ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando 3 Feb, 2007 Influenza: Preparing for the Next Pandemic 15 Oct, 2012 Disease-free survival doubles for patients treated with immunoconjugate TDM-1 for their HER-2 positive metastatic breast cancers 19 Nov, 2013
- Previous story Preventing ER-Positive Breast Cancer—Latest from IBIS 1, 2 and 3
- Next story Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014